Current Valuation: Synthorx (NASDAQ: THOR)
Synthorx is in the biotechnology industry and trades as part of the healthcare sector. The company CEO is Laura Shawver.
Previous Intraday Performance:
The THOR shares had a previous change of 5.43% which opened at 12.36 and closed at 13.01. It moved to an intraday high of 13.16 and a low of 12.19.
SeekingAlpha: Synthorx misses by $0.07
Historical Performance:
Over the last five trading days, THOR shares returned 4.92% and in the past 30 trading days it returned -22.61%. Over three months, it changed -27.32%. In one year it has changed 3.17% and within that year its 52 week high was 23.53 and its 52 week low was 11.00. THOR stock is 18.27% above its 52 week low.
Our calculations result in a 50 day moving average of 16.45.
SeekingAlpha: Synthorx misses by $0.07
Liquidity:
The company has a market cap of $418.2m with 32.1m shares outstanding and a float of 32.1m shares. Trading volume was 61,239 shares and has experienced an average volume of 83,746 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Synthorx was -18.11 which ended on 31st of December 2018. Based on 1 analyst estimate, the estimated EPS for the next quarter is -0.12.
Below was the last reported quarterly diluted earnings per share:
| 1st | Qtr 2019 | Reported 04-30-2019: | -0.35 |
|---|---|---|---|
| 4th | Qtr 2018 | Reported 03-12-2019: | -2.94 |
| 3rd | Qtr 2018 | Reported 11-04-2015: | 0.00 |
| 1st | Qtr 2018 | Reported 08-04-2015: | 0.00 |
| 4th | Qtr 2017 | Reported 05-07-2015: | -0.70 |
The growth of the EPS is critical in understanding the current valuation of Synthorx.
Indicators Also to Watch:
Based on the latest filings, there is 73.80% of institutional ownership.
The beta was calculated to be -0.72.
SeekingAlpha: Oil surges 3% on incident in Gulf of Oman
Fundamental Numbers:
Based on last reported financials, the company’s return on assets is -35.23% and price-to-book is 2.28.
Company Score Card:
Results are out of six:
0 : Growth Expectations Result
6 : Financial Safety Result
0 : Past Performance Result
1 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result
Related
